Ocugen Income Statement (2014-2026) | OCGN

Income Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.50M0.64M0.47M0.88M0.44M0.48M3.70M1.41M1.01M1.14M1.14M0.76M1.48M1.37M1.75M-0.19M1.53M
Operating items
Research & Development (Quarter)
18.85M6.28M7.10M9.39M11.60M17.94M17.23M10.17M14.57M7.05M7.78M6.83M8.90M8.11M8.29M9.53M8.40M11.15M10.67M11.26M
Selling, General & Administrative (Quarter)
6.76M4.51M7.47M10.14M10.62M7.64M7.01M8.31M9.45M9.08M5.16M6.40M7.69M6.28M6.31M6.45M6.77M8.23M6.13M8.12M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
25.61M10.79M14.57M19.53M22.22M25.58M24.23M18.48M24.02M16.13M12.93M13.23M16.59M14.39M14.60M15.98M15.17M19.38M16.80M19.37M
Operating Income (Quarter)
-25.61M-10.79M-14.57M-19.03M-21.58M-25.11M-23.36M-18.04M-23.54M-12.43M-11.53M-12.22M-15.45M-13.25M-13.84M-14.50M-13.79M-17.62M-17.00M-17.84M
EBIT (Quarter)
-25.61M-10.79M-14.57M-19.03M-21.58M-25.11M-23.36M-18.04M-23.54M-12.43M-11.53M-12.22M-15.45M-13.25M-13.84M-14.50M-13.79M-17.62M-17.00M-17.84M
Non-operating items
Interest & Investment Income (Quarter)
0.01M0.01M0.30M0.50M0.30M0.21M0.29M0.10M
Other Non Operating Income (Quarter)
-0.33M-0.00M0.34M0.01M0.00M0.15M0.07M-1.32M0.48M-0.15M
Non Operating Income (Quarter)
-0.34M-0.02M-0.01M0.01M0.09M1.20M0.96M0.71M0.47M0.71M0.56M-0.01M-0.00M0.28M-0.04M-0.85M0.11M-2.43M-0.71M-1.34M
Net income details
EBT (Quarter)
-85.16M-10.81M-14.58M-33.50M-27.15M-21.92M-21.94M-22.85M-28.17M-16.87M-123.94M-18.41M-20.98M-12.98M-13.94M-15.46M-20.14M-18.73M-18.03M-35.86M
Tax Provisions (Quarter)
-0.05M
Profit After Tax (Quarter)
-25.95M-10.76M-14.58M-19.02M-21.48M-23.91M-22.40M-17.33M-23.07M-11.72M-11.00M-11.92M-15.28M-12.97M-13.83M-15.36M-14.74M-20.05M-17.66M-19.20M
Income from Continuing Operations (Quarter)
-85.16M-10.76M-14.58M-33.50M-27.15M-21.92M-21.94M-22.85M-28.17M-16.87M-123.94M-18.41M-20.98M-12.98M-13.94M-15.46M-20.14M-18.73M-18.03M-35.86M
Consolidated Net Income (Quarter)
-85.16M-10.76M-14.58M-33.50M-27.15M-21.92M-21.94M-22.85M-28.17M-16.87M-123.94M-18.41M-20.98M-12.98M-13.94M-15.46M-20.14M-18.73M-18.03M-35.86M
Income towards Parent Company (Quarter)
-85.16M-10.76M-14.58M-33.50M-27.15M-21.92M-21.94M-22.85M-28.17M-16.87M-123.94M-18.41M-20.98M-12.98M-13.94M-15.46M-20.14M-18.73M-18.03M-35.86M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-25.95M-10.76M-14.58M-33.50M-27.15M-21.92M-21.94M-22.85M-23.07M-11.72M-63.08M-10.29M40.08M-15.35M-19.18M
Additional items
EPS (Basic) (Quarter)
-0.13-0.05-0.07-0.16-0.13-0.10-0.10-0.10-0.10-0.05-0.26-0.042.05-0.05-0.06
EPS (Diluted) (Quarter)
-0.13-0.05-0.07-0.16-0.13-0.10-0.10-0.10-0.10-0.05-0.26-0.040.16-0.05-0.06
Shares Outstanding (Quarter)
195.57M198.79M195.01M205.69M215.86M216.59M214.60M225.52M238.31M256.49M244.33M257.23M257.35M19.64M19.60M292.00M28.95M49.63M50.23M327.54M
Shares Outstanding (Diluted) (Quarter)
195.57M198.79M195.01M205.69M215.86M216.59M214.60M225.52M238.31M256.49M244.33M257.23M257.35M257.35M257.35M292.00M292.00M292.00M292.00M327.54M
Shares Outstanding (Entity) (Quarter)
198.82M199.05M199.50M215.75M216.27M216.81M221.72M226.55M238.31M19.64M19.60M28.95M49.63M50.23M
EBITDA (Quarter)
-25.61M-10.79M-14.57M-19.03M-21.58M-25.11M-23.36M-18.04M-23.54M-12.43M-11.53M-12.22M-15.45M-13.25M-13.84M-14.50M-13.79M-17.62M-17.00M-17.84M
Interest Expenses (Quarter)
59.56M49.55M0.02M14.47M5.57M5.20M95.72M4.82M4.63M4.44M112.41M6.19M5.54M0.03M0.60M1.26M6.35M1.31M1.33M18.12M
Tax Rate (Quarter)
0.48%